冠昊生物：2025年第三季度营业收入同比增长4.72%

Core Insights - The company reported a revenue of 92,610,785.08 yuan for the third quarter of 2025, representing a year-on-year increase of 4.72% [1] - The net profit attributable to shareholders of the listed company was 6,314,402.45 yuan, showing a year-on-year decrease of 17.87% [1] Financial Performance - Revenue for Q3 2025: 92.61 million yuan, up 4.72% year-on-year [1] - Net profit for Q3 2025: 6.31 million yuan, down 17.87% year-on-year [1]